Supplementary tables
The information of human patients
Patients
Normal patients with acute injury Diabetic patients with acute injury Gender and age Table 2 T  GCAGTGATGTGATGAATTA  TTCAAGAGA  TAATTCATCACATCACTGC  TTTTTTC   REG3A-shRNA-1R  TCGAGAAAAAA  GCAGTGATGTGATGAATTA  TCTCTTGAA  TAATTCATCACATCACTGC  A   REG3A-shRNA-4F  T  GTGAAGAGCATTGGTAACA  TTCAAGAGA  TGTTACCAATGCTCTTCAC  TTTTTTC   REG3A-shRNA-4R  TCGAGAAAAAA  GTGAAGAGCATTGGTAACA  TCTCTTGAA  TGTTACCAATGCTCTTCAC  A   REG3A-shRNA-5F  T  GTAACAGCTACTCATACGT  TTCAAGAGA  ACGTATGAGTAGCTGTTAC by a Ni 2+ -nitrilotriacetic acid resin (NTA) column after 1mM IPTG induction for 4h, and went through the Hitrap Q FF column to remove the endotoxin according to the manufacturer's instructions (GE Healthcare).
Excisional wound model
Dorsal mouse fur from age-matched control and NOD mice (30 weeks, female), or (Lepr db/+ ) mice and mice homozygous for the diabetes spontaneous mutation (Lepr db/db ) (8-10 weeks, male) was removed by plucking or using chemical depilation (Veet) under isoflurane anesthesia. Excisional dorsal skin wounds were made with a 5 mm or an 8mm sterile biopsy punch. Mice were euthanized on day 3, 5, 7 post-wounding, and 5mm skin surrounding wound edges was used for immunohistochemical analysis, 2mm skin surrounding wound edges was collected for qPCR.
Quantitative RT-PCR
Total RNA was extracted from mouse wound homogenates using TRIzol ® reagent (Life Real-Time PCR System (Applied Biosystem). Samples with low yield of RNA were pre-determined and excluded.
Semi-quantitative RT-PCR
Total RNA was extracted from cells using TRIzol ® reagent (Life Technologies) following the manufacturer's introduction. Equal amounts of total RNA from each sample were reversed using cDNA Reverse Transcriptase kit (Roche). The RT reaction was then amplified for house-keeping gene cDNA (GADPH) and specific cDNA of interest using gene-specific primers (Table 5 ). After PCR, same volumes of reaction products were electrophoresed on a 1% agarose gel. Uncropped images of the agarose gels for Supplementary Fig.5 are shown in Supplementary Fig.14. 
